Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.

about

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.

Item

http://www.wikidata.org/entity/Q49630159

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@en

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@nl

type

Item

label

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@en

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@nl

prefLabel

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@en

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@nl

P1476

Advances in micro- and nanotec ...... ging of pancreatic beta-cells.

@en

P2093

Chris I Richards

http://www.w3.org/2001/XMLSchema#string

Corey B Hughes

http://www.w3.org/2001/XMLSchema#string

Faruk H Moonschi

http://www.w3.org/2001/XMLSchema#string

George M Mussman

http://www.w3.org/2001/XMLSchema#string

Iuliana Popescu

http://www.w3.org/2001/XMLSchema#string

John L Fowlkes

http://www.w3.org/2001/XMLSchema#string

P2860

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Pharmacology, physiology, and mechanisms of incretin hormone action

Nanotechnology in cancer therapy

Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers

GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging.

A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1

Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice.

Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity

Effect of pegylation on pharmaceuticals.

P2888

s00592-017-1086-7

P31

scholarly article

review article

P356

10.1007/S00592-017-1086-7

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099744004

http://www.w3.org/2001/XMLSchema#string

P698

29264724

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology